Bafna Pharmaceuticals informs about board meeting

15 May 2013 Evaluate

Bafna Pharmaceuticals has informed that a meeting of the board of directors of the company will be held on May 20, 2013, to consider and approve Audited Financial Results of the Company for the year ended March 31, 2013 on Standalone and Consolidated basis and to recommend payment of dividend, if any.

Further, the board to consider re-appointment of Bafna Mahaveer Chand as Chairman and Managing Director and Paras Bafna as Whole Time Director.

The above information is a part of company’s filings submitted to BSE.

Bafna Pharma Share Price

146.35 2.85 (1.99%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×